35288208|t|Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2.
35288208|a|The current SARS-CoV-2 pandemic, along with the likelihood that new coronavirus strains will appear in the nearby future, highlights the urgent need to develop new effective antiviral agents. In this scenario, emerging host-targeting antivirals (HTAs), which act on host-cell factors essential for viral replication, are a promising class of antiviral compounds. Here we show that a new class of HTAs targeting peptidylarginine deiminases (PADs), a family of calcium-dependent enzymes catalyzing protein citrullination, is endowed with a potent inhibitory activity against human beta-coronaviruses (HCoVs). Specifically, we show that infection of human fetal lung fibroblasts with HCoV-OC43 leads to enhanced protein citrullination through transcriptional activation of PAD4, and that inhibition of PAD4-mediated citrullination with either of the two pan-PAD inhibitors Cl-A and BB-Cl or the PAD4-specific inhibitor GSK199 curbs HCoV-OC43 replication. Furthermore, we show that either Cl-A or BB-Cl treatment of African green monkey kidney Vero-E6 cells, a widely used cell system to study beta-CoV replication, potently suppresses HCoV-OC43 and SARS-CoV-2 replication. Overall, our results demonstrate the potential efficacy of PAD inhibitors, in suppressing HCoV infection, which may provide the rationale for the repurposing of this class of inhibitors for the treatment of COVID-19 patients.
35288208	28	31	PAD	Gene	23569
35288208	51	56	human	Species	9606
35288208	57	75	beta-coronaviruses	Species	694002
35288208	76	85	HCoV-OC43	Species	31631
35288208	90	100	SARS-CoV-2	Species	2697049
35288208	114	124	SARS-CoV-2	Disease	MESH:D000086382
35288208	170	181	coronavirus	Disease	MESH:D018352
35288208	561	568	calcium	Chemical	MESH:D002118
35288208	675	680	human	Species	9606
35288208	681	699	beta-coronaviruses	Species	694002
35288208	701	706	HCoVs	Species	2501931
35288208	749	754	human	Species	9606
35288208	783	792	HCoV-OC43	Species	31631
35288208	872	876	PAD4	Gene	23569
35288208	901	905	PAD4	Gene	23569
35288208	957	960	PAD	Gene	23569
35288208	972	976	Cl-A	Chemical	-
35288208	981	986	BB-Cl	Chemical	-
35288208	994	998	PAD4	Gene	23569
35288208	1018	1024	GSK199	Chemical	MESH:C000607177
35288208	1031	1040	HCoV-OC43	Species	31631
35288208	1087	1091	Cl-A	Chemical	-
35288208	1095	1100	BB-Cl	Chemical	-
35288208	1114	1134	African green monkey	Species	9534
35288208	1147	1149	E6	CellLine	CVCL:B6C7
35288208	1192	1200	beta-CoV	Species	694002
35288208	1234	1243	HCoV-OC43	Species	31631
35288208	1248	1258	SARS-CoV-2	Species	2697049
35288208	1331	1334	PAD	Gene	23569
35288208	1362	1376	HCoV infection	Disease	MESH:D007239
35288208	1479	1487	COVID-19	Disease	MESH:D000086382
35288208	1488	1496	patients	Species	9606
35288208	Association	MESH:D007239	23569
35288208	Negative_Correlation	MESH:C000607177	23569
35288208	Association	MESH:D000086382	23569

